CARDIOPULMONARY COMORBIDITY: EFFECTS OF CARDIOVASCULAR DISEASES ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND NEWLY DIAGNOSED TUBERCULOSIS
https://doi.org/10.29001/2073-8552-2017-32-1-70-73
Abstract
The purpose of the study was to track the frequency of occurrence of cardiovascular diseases in patients with newly diagnosed tuberculosis, and tuberculosis in combination with chronic obstructive pulmonary disease. A comparative retrospective study comprised a total of 232 patients including 116 patients with TB and 116 patients with TB in combination with COPD. Cardiovascular diseases (CVD) were diagnosed in 28 people (24.1%) in group 1. Cardiovascular disease occurred statistically significantly more frequently in women: 25 women (22%) versus 3 men (2%) (p<0.05). In group 2, 44 individuals (37.9%) had CVD. Hypertension was found in 21 individuals (17%); ischemic heart disease was observed in 12 individuals (10%); and chronic heart failure was found in 11 people (9%). In this group, CVD incidence rate was significantly higher in men (34%) than in women (3%) (p<0.05). In tuberculosis group, lower incidence rate and later peak (from 61 to 90 years) of CVD development were observed which was possibly due to less exposure to risk factors (smoking, etc.). In group 1, 32 individuals (27.6%) were smokers and, among then, five patients (15.6%) had CVD. In group 2, 111 (95.1%) individuals were smokers and 40 (36%) of them had CVD (χ2=8.928; р=0.05). In group 1, 13 (11.2%) individuals showed alcohol abuse; one patient (7.7%) had CVD. In group 2, 71 (62.1%) individuals showed alcohol abuse; 22 patients (31%) had CVD (χ2=6,446; p=0.05). Mortality rates were 3.4% in tuberculosis group and 15.5% in group of TB and COPD; half of deceased individuals had history of cardiovascular events (χ2=6.465; p=0.005). The lack of treatment efficacy in the presence of CVD was documented in 37% and 33% (χ2=3,769; p=0.165), respectively. The presence of COPD and tuberculosis increase the frequency of CVD; combination of CVD with COPD and tuberculosis significantly aggravate the course of the main and the concomitant disease.
About the Authors
M. R. Ibragimova
Omsk State Medical University
Russian Federation
Russian Federation
N. V. Bagisheva
Omsk State Medical University
A.N. Kabanov Clinical Hospital No. 1
Russian Federation
Russian Federation
A. R. Ibragimova
Omsk State Medical University
Russian Federation
Russian Federation
References
1. Ford E.S., Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment public health versus clinical care // Ann. Rev. Public Health. – 2011. – Vol. 32. – P. 5–22.
2. Шальнова С.А. Распространенность ИБС в сочетании с другими неинфекционными заболеваниями в популяции взрослого населения // Сочетанная патология внутр. болезней. – 2015. – Т. 38. – С. 5–14.
3. St Sauver J.L., Boyd C.M., Grossardt B.R. et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity [Electronic resource] // BMJ Open. – 2015. – Vol. 5. – P. e006413. – Doi: 10.1136/bmjopen.
4. Гельцер Б.И., Бродская Т.А., Невзорова В.А. Артериальная ригидность и хроническая обструктивная болезнь легких: патофизиологические взаимосвязи и клиническое значение // Тер. архив. – 2008. – № 11. – С. 89–94.
5. Даниляк И.Г. Хронические обструктивные заболевания легких и ишемическая болезнь сердца // Пульмонология. – 1992. – № 2. – С. 22–23.
6. Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis // Eur. Respir. J. – 2003. – Vol. 22. – P. 809–814.
7. Всемирная организация здравоохранения. Глобальная борьба с туберкулезом 2011 года. – Женева : ВОЗ, 2011.
Review
For citations:
Ibragimova M.R., Bagisheva N.V., Ibragimova A.R. CARDIOPULMONARY COMORBIDITY: EFFECTS OF CARDIOVASCULAR DISEASES ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND NEWLY DIAGNOSED TUBERCULOSIS. Siberian Journal of Clinical and Experimental Medicine. 2017;32(1):70-73. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-1-70-73
Views:
840
.png)
Email this article 